ITOS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Iteos Therapeutics Inc (ITOS).


$280.58M Market Cap.

As of 03/05/2025 5:00 PM ET (MRY) • Disclaimer

ITOS Market Cap. (MRY)


ITOS Shares Outstanding (MRY)


ITOS Assets (MRY)


Total Assets

$686.98M

Total Liabilities

$96.68M

Total Investments

$512.87M

ITOS Income (MRY)


Revenue

$35.00M

Net Income

-$134.41M

Operating Expense

$194.53M

ITOS Cash Flow (MRY)


CF Operations

-$98.18M

CF Investing

-$131.15M

CF Financing

$122.24M

ITOS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ITOS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$686,976,000 (2.90%)

$667,588,000 (-11.58%)

$754,991,000 (-14.66%)

$884,712,000 (156.77%)

Assets Current

$509,539,000 (-7.47%)

$550,652,000 (-12.36%)

$628,298,000 (-28.17%)

$874,713,000 (157.61%)

Assets Non-Current

$177,437,000 (51.74%)

$116,936,000 (-7.70%)

$126,693,000 (1167.06%)

$9,999,000 (99.42%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$590,294,000 (2.62%)

$575,228,000 (-13.28%)

$663,332,000 (19.99%)

$552,820,000 (71.05%)

Property Plant & Equipment Net

$9,984,000 (-6.97%)

$10,732,000 (58.45%)

$6,773,000 (-8.49%)

$7,401,000 (447.41%)

Cash & Equivalents

$142,430,000 (-43.36%)

$251,451,000 (-11.78%)

$285,038,000 (-66.42%)

$848,835,000 (152.29%)

Accumulated Other Comprehensive Income

-$15,999,000 (-20.84%)

-$13,240,000 (-37.29%)

-$9,644,000 (-847.35%)

-$1,018,000 (-264.99%)

Deferred Revenue

$1,397,000 (-32.28%)

$2,063,000 (-85.02%)

$13,775,000 (-95.10%)

$281,052,000 (6165.09%)

Total Investments

$512,871,000 (34.51%)

$381,278,000 (-14.62%)

$446,584,000 (0%)

$0 (0%)

Investments Current

$352,517,000 (25.57%)

$280,739,000 (-14.50%)

$328,359,000 (0%)

$0 (0%)

Investments Non-Current

$160,354,000 (59.49%)

$100,539,000 (-14.96%)

$118,225,000 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$805,000 (0%)

$0 (0%)

$1,001,000 (-75.11%)

$4,022,000 (2924.06%)

Trade & Non-Trade Payables

$8,503,000 (-59.66%)

$21,080,000 (175.12%)

$7,662,000 (48.92%)

$5,145,000 (70.03%)

Accumulated Retained Earnings (Deficit)

-$9,781,000 (-107.85%)

$124,633,000 (-47.47%)

$237,275,000 (68.73%)

$140,623,000 (290.29%)

Tax Assets

$8,792,000 (-20.13%)

$11,008,000 (329.66%)

$2,562,000 (-74.56%)

$10,072,000 (189.59%)

Tax Liabilities

$46,720,000 (14.15%)

$40,930,000 (4.41%)

$39,200,000 (130.59%)

$17,000,000 (0%)

Total Debt

$5,096,000 (-15.88%)

$6,058,000 (29.64%)

$4,673,000 (-12.51%)

$5,341,000 (0%)

Debt Current

$1,336,000 (6.79%)

$1,251,000 (49.64%)

$836,000 (8.57%)

$770,000 (0%)

Debt Non-Current

$3,760,000 (-21.78%)

$4,807,000 (25.28%)

$3,837,000 (-16.06%)

$4,571,000 (0%)

Total Liabilities

$96,682,000 (4.68%)

$92,360,000 (0.76%)

$91,659,000 (-72.38%)

$331,892,000 (1453.73%)

Liabilities Current

$40,360,000 (0.86%)

$40,014,000 (-4.73%)

$42,000,000 (-86.19%)

$304,124,000 (1927.76%)

Liabilities Non-Current

$56,322,000 (7.60%)

$52,346,000 (5.41%)

$49,659,000 (78.84%)

$27,768,000 (336.40%)

ITOS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$35,000,000 (177.89%)

$12,595,000 (-95.29%)

$267,630,000 (-22.38%)

$344,775,000 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$49,081,000 (-2.61%)

$50,396,000 (14.67%)

$43,947,000 (8.50%)

$40,505,000 (164.05%)

Research & Development Expense

$145,447,000 (28.37%)

$113,300,000 (16.37%)

$97,359,000 (63.99%)

$59,369,000 (98.56%)

Operating Expenses

$194,528,000 (18.83%)

$163,696,000 (15.85%)

$141,306,000 (41.48%)

$99,874,000 (120.76%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$14,072,000 (289.59%)

$3,612,000 (-93.07%)

$52,084,000 (24.18%)

$41,943,000 (73684.21%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$134,414,000 (-19.33%)

-$112,642,000 (-216.54%)

$96,652,000 (-54.95%)

$214,521,000 (664.04%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$134,414,000 (-19.33%)

-$112,642,000 (-216.54%)

$96,652,000 (-54.95%)

$214,521,000 (664.04%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$134,414,000 (-19.33%)

-$112,642,000 (-216.54%)

$96,652,000 (-54.95%)

$214,521,000 (594.27%)

Weighted Average Shares

$40,474,385 (13.17%)

$35,763,520 (0.59%)

$35,552,025 (1.05%)

$35,181,383 (133.29%)

Weighted Average Shares Diluted

$40,474,385 (13.17%)

$35,763,520 (-5.30%)

$37,766,507 (-0.02%)

$37,774,790 (150.49%)

Earning Before Interest & Taxes (EBIT)

-$120,342,000 (-10.38%)

-$109,030,000 (-173.30%)

$148,736,000 (-42.01%)

$256,464,000 (773.31%)

Gross Profit

$35,000,000 (177.89%)

$12,595,000 (-95.29%)

$267,630,000 (-22.38%)

$344,775,000 (0%)

Operating Income

-$159,528,000 (-5.58%)

-$151,101,000 (-219.61%)

$126,324,000 (-48.42%)

$244,901,000 (641.34%)

ITOS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$131,151,000 (-280.50%)

$72,658,000 (116.29%)

-$446,062,000 (-35814.81%)

-$1,242,000 (-229.44%)

Net Cash Flow from Financing

$122,241,000 (10883.02%)

$1,113,000 (-43.90%)

$1,984,000 (-45.78%)

$3,659,000 (-98.92%)

Net Cash Flow from Operations

-$98,181,000 (5.37%)

-$103,756,000 (6.69%)

-$111,193,000 (-121.67%)

$513,140,000 (2138.21%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$109,021,000 (-224.59%)

-$33,587,000 (94.04%)

-$563,797,000 (-210.03%)

$512,381,000 (61.91%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$129,493,000 (-271.01%)

$75,723,000 (117.02%)

-$445,004,000 (0%)

$0 (0%)

Capital Expenditure

-$1,633,000 (44.94%)

-$2,966,000 (-216.20%)

-$938,000 (20.58%)

-$1,181,000 (-231.74%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$122,718,000 (10925.88%)

$1,113,000 (20.32%)

$925,000 (-68.57%)

$2,943,000 (-98.61%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$1,930,000 (46.42%)

-$3,602,000 (57.75%)

-$8,526,000 (-168.45%)

-$3,176,000 (-289.27%)

Share Based Compensation

$29,941,000 (10.81%)

$27,021,000 (25.32%)

$21,561,000 (56.31%)

$13,794,000 (221.39%)

Depreciation Amortization & Accretion

$1,238,000 (37.86%)

$898,000 (11.83%)

$803,000 (33.17%)

$603,000 (12.71%)

ITOS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00%

Profit Margin

-384.00% (57.06%)

-894.30% (-2577.29%)

36.10% (-41.96%)

62.20%

EBITDA Margin

-340.30% (60.36%)

-858.50% (-1635.78%)

55.90% (-25.07%)

74.60%

Return on Average Equity (ROAE)

-22.20% (-20.65%)

-18.40% (-221.85%)

15.10% (-73.13%)

56.20% (285.48%)

Return on Average Assets (ROAA)

-19.30% (-19.14%)

-16.20% (-233.88%)

12.10% (-65.33%)

34.90% (299.43%)

Return on Sales (ROS)

-343.80% (60.29%)

-865.70% (-1657.01%)

55.60% (-25.27%)

74.40%

Return on Invested Capital (ROIC)

-24.10% (1.63%)

-24.50% (-105.26%)

465.70% (453.88%)

-131.60% (-108.24%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.31 (33.46%)

-3.48 (-148.41%)

7.18 (-5.93%)

7.63 (165.00%)

Price to Sales Ratio (P/S)

8.88 (-71.44%)

31.09 (1098.65%)

2.59 (-45.40%)

4.75

Price to Book Ratio (P/B)

0.47 (-30.25%)

0.68 (-34.96%)

1.05 (-64.76%)

2.97 (-18.98%)

Debt to Equity Ratio (D/E)

0.16 (1.86%)

0.16 (16.67%)

0.14 (-77.00%)

0.6 (809.09%)

Earnings Per Share (EPS)

-3.32 (-5.40%)

-3.15 (-215.81%)

2.72 (-55.41%)

6.1 (311.81%)

Sales Per Share (SPS)

0.86 (145.74%)

0.35 (-95.32%)

7.53 (-23.18%)

9.8 (0%)

Free Cash Flow Per Share (FCFPS)

-2.47 (17.36%)

-2.98 (5.39%)

-3.15 (-121.67%)

14.55 (959.54%)

Book Value Per Share (BVPS)

14.58 (-9.33%)

16.08 (-13.80%)

18.66 (18.74%)

15.71 (-26.68%)

Tangible Assets Book Value Per Share (TABVPS)

16.97 (-9.07%)

18.67 (-12.10%)

21.24 (-15.55%)

25.15 (10.06%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (50.00%)

-2 (0%)

0 (0%)

3 (113.64%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.36 (23.88%)

-1.79 (-402.25%)

-0.36 (-112.28%)

2.9 (112.88%)

Asset Turnover

0.05 (177.78%)

0.02 (-94.63%)

0.34 (-40.29%)

0.56 (0%)

Current Ratio

12.63 (-8.26%)

13.76 (-8.01%)

14.96 (420.13%)

2.88 (-87.30%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$99,814,000 (6.47%)

-$106,722,000 (4.82%)

-$112,131,000 (-121.90%)

$511,959,000 (2105.17%)

Enterprise Value (EV)

$162,054,490 (-16.20%)

$193,373,290 (463.57%)

-$53,187,942 (-107.14%)

$745,317,458 (-11.81%)

Earnings Before Tax (EBT)

-$120,342,000 (-10.38%)

-$109,030,000 (-173.30%)

$148,736,000 (-42.01%)

$256,464,000 (773.31%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$119,104,000 (-10.15%)

-$108,132,000 (-172.31%)

$149,539,000 (-41.83%)

$257,067,000 (784.51%)

Invested Capital

$509,282,000 (33.26%)

$382,181,000 (-11.66%)

$432,626,000 (264.56%)

-$262,906,000 (-3713.55%)

Working Capital

$469,179,000 (-8.12%)

$510,638,000 (-12.90%)

$586,298,000 (2.75%)

$570,589,000 (75.81%)

Tangible Asset Value

$686,976,000 (2.90%)

$667,588,000 (-11.58%)

$754,991,000 (-14.66%)

$884,712,000 (156.77%)

Market Capitalization

$280,580,490 (-28.40%)

$391,845,290 (-43.60%)

$694,786,058 (-57.70%)

$1,642,352,458 (38.57%)

Average Equity

$606,763,500 (-0.91%)

$612,319,500 (-4.37%)

$640,302,500 (67.73%)

$381,741,500 (166.78%)

Average Assets

$697,915,750 (0.52%)

$694,331,000 (-13.15%)

$799,489,750 (30.07%)

$614,666,250 (147.18%)

Invested Capital Average

$500,356,250 (12.64%)

$444,208,750 (1290.72%)

$31,941,000 (116.39%)

-$194,823,750 (-8072.14%)

Shares

36,533,918 (2.09%)

35,784,958 (0.59%)

35,575,323 (0.85%)

35,273,893 (0.65%)